REVAKINAGENE TARORETCEL
UNII Q7V7NYG6GM

Substance Identification & Data

This profile provides standardized clinical and technical data for Revakinagene Taroretcel, uniquely identified by the FDA Unique Ingredient Identifier (UNII) Q7V7NYG6GM.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

Q7V7NYG6GM

CAS Registry Number

N/A

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

REVAKINAGENE TARORETCEL

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

Q7V7NYG6GM

The specific atomic composition represented as a molecular structure string.

NCI Thesaurus

C180656

National Cancer Institute reference terminology for clinical and research data.

INN ID

11375

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

LM-47

Identifier assigned by the United States Adopted Names Council.

Substance Type

structurallyDiverse

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

ITIS TSN

180092

Taxonomic Serial Number for species identified in the Integrated Taxonomic Information System.

NCBI Taxonomy

9606

Unique numeric identifier used to specify biological species in the NCBI database.

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Revakinagene Taroretcel. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

REVAKINAGENE TARORETCEL

REVAKINAGENE TARORETCEL-LWEY

Common Names & Synonyms

AN ALLOGENEIC HUMAN ADULT RETINAL PIGMENT EPITHELIAL (RPE) CELLLINE STABLY TRANSFECTED WITH A PLASMID ENCODING HUMAN CILIARY NEUROTROPHIC FACTOR (CNTF) FUSED IN FRAME TO THE MURINE IMMUNOGLOBULIN MU-FACTOR VDJ4C1 SIGNAL PEPTIDE, UNDER THE CONTROL OF A MOUSE METALLOTHIONEIN PROMOTER AND A HUMAN GROWTH HORMONE POLYADENYLATION SIGNAL. THE PLASMID ALSO CONTAINS THREE EUKARYOTIC EXPRESSION CASSETTES FOR THE SELECTABLE MARKERS NEOMYCIN RESISTANCE, MOUSE DHFR (DIHYDROFOLATE REDUCTASE) AND HSV-TK (THYMIDINE KINASE), PLUS THE BACTERIAL COMPONENTS OF THE PUC18 BACKBONE, INCLUDING THE AMPICILLIN RESISTANCE GENE (AMPR), ORIGIN OF REPLICATION (ORI) AND LACZ GENE (ALPHA FRAGMENT OF .BETA.-GALACTOSIDASE)

REVAKINAGENE TARORETCEL [INN]

REVAKINAGENE TARORETCEL [USAN]

REVAKINAGENE TARORETCEL [WHO-DD]

REVAKINAGENE TARORETCEL LWEY [WHO-DD]